Magnus Financial Group LLC Madrigal Pharmaceuticals, Inc. Transaction History

Magnus Financial Group LLC

  • $1.01 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 05, 2021
SELL
$108.54 - $125.2 $1.5 Million - $1.73 Million
-13,820 Closed
0 $0
Q2 2020

Aug 11, 2020
SELL
$60.13 - $125.71 $216,047 - $451,676
-3,593 Reduced 20.63%
13,820 $1.57 Million
Q1 2019

May 09, 2019
BUY
$103.48 - $143.84 $1.8 Million - $2.5 Million
17,413 New
17,413 $2.18 Million

Others Institutions Holding MDGL

# of Institutions
303
Shares Held
22M
Call Options Held
819K
Put Options Held
644K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.69B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Magnus Financial Group LLC Portfolio

Follow Magnus Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnus Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnus Financial Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email